Bartlett & Co Wealth Management’s Sana Biotechnology SANA Stock Holding History

Bartlett & Co Wealth Management’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$341	Hold	100	–	–	﹤0.01%	1184
2025 Q4	$407	Hold	100	–	–	﹤0.01%	1175
2025 Q3	$355	Hold	100	–	–	﹤0.01%	1147
2025 Q2	$273	Hold	100	–	–	﹤0.01%	1186
2025 Q1	$168	Hold	100	–	–	﹤0.01%	1178
2024 Q4	$163	Hold	100	–	–	﹤0.01%	1103
2024 Q3	$416	Hold	100	–	–	﹤0.01%	1096
2024 Q2	$546	Hold	100	–	–	﹤0.01%	1099
2024 Q1	$1K	Hold	100	–	–	﹤0.01%	1070
2023 Q4	$435	Hold	100	–	–	﹤0.01%	1200
2023 Q3	$387	Hold	100	–	–	﹤0.01%	1135
2023 Q2	$596	Hold	100	–	–	﹤0.01%	1114
2023 Q1	$327	Hold	100	–	–	﹤0.01%	1040
2022 Q4	$395	Hold	100	–	–	﹤0.01%	1072
2022 Q3	$600	Hold	100	–	–	﹤0.01%	1135
2022 Q2	$643	Hold	100	–	–	﹤0.01%	1262
2022 Q1	$826	Buy	+100	New	+$809	﹤0.01%	1031

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marex Group London $15.8B AUM 31.44% 1-Year Est. Return

IHAM

Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Bartlett & Co Wealth Management's SANA Position: Q1 2026 in Review

Bartlett & Co Wealth Management held its Sana Biotechnology (SANA) position steady in Q1 2026 at 100 shares worth $341. The position accounts for ﹤0.01% of the portfolio, ranked #1184.

Bartlett & Co Wealth Management first reported a position in SANA in Q1 2022 and has held it in 17 quarters since. The position peaked at $1K in Q1 2024. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

Bartlett & Co Wealth Management held 100 shares of Sana Biotechnology worth $341 as of Q1 2026.
Bartlett & Co Wealth Management left its Sana Biotechnology share count unchanged in Q1 2026.
Sana Biotechnology made up ﹤0.01% of Bartlett & Co Wealth Management's portfolio in Q1 2026, its #1184 holding.
Bartlett & Co Wealth Management first reported a position in Sana Biotechnology in Q1 2022 and has held it in 17 quarters since.
Bartlett & Co Wealth Management's Sana Biotechnology position peaked at $1K in Q1 2024.
202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Bartlett & Co Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.